Strides Pharma Science

Strides Pharma Science CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Strides Pharma Science (STAR.NS) as of Nov 22, 2026 is 35.43 %. In the previous year, CapEx to Operating Cash Flow Ratio was 16.86 % — a change of 110.22% (higher).

CapEx/OCF

35.43 %

YoY

110.22%

Last updated:

CapEx to Operating Cash Flow Ratio of Strides Pharma Science is 2025 35.43 % . CapEx to Operating Cash Flow Ratio of Strides Pharma Science was 2024 16.86 % . It decreases by 110.22% higher compared to the previous year.

The Strides Pharma Science CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
234.62 INR
Jan 1, 2019
547.92 INR
Jan 1, 2020
73.25 INR
Jan 1, 2021
61.79 INR
Jan 1, 2022
-55.61 INR
Jan 1, 2023
215.42 INR
Jan 1, 2024
16.86 INR
Jan 1, 2025
35.43 INR
The Strides Pharma Science CapEx/OCF history
YEARCapEx/OCFYoY
35.43 %+110.22%
16.86 %-92.17%
215.42 %-487.35%
-55.61 %-190.00%
61.79 %-15.64%
73.25 %-86.63%
547.92 %+133.54%
234.62 %-186.17%
-272.26 %-166.06%
412.11 %+42.04%
290.13 %-280.31%
-160.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Strides Pharma Science Stock analysis

What does Strides Pharma Science do? Strides Pharma Science Ltd. generates revenue through the development, manufacturing, and distribution of IP-led generics and bio-pharmaceutical products across its Pharmaceutical and Bio-pharmaceutical segments. The company serves global markets including Africa, Australia, Asia (excluding India), North America, Europe, India, and Others, offering niche pharmaceutical products in various dosage forms such as liquids, creams, ointments, soft gels, sachets, tablets, and modified release formats. Its manufacturing units in Bengaluru, Puducherry, Chennai, Singapore, Milan, Florida, and Nairobi produce anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drugs, alongside soft gelatin capsules. The firm's revenue streams are derived from the sale of its IP-led niche pharmaceutical products to healthcare providers, distributors, and global pharmaceutical companies operating in the specified geographical segments. Key product categories include anti-retroviral, anti-malarial, anti-tuberculosis, and hepatitis treatments, which are distributed through its global manufacturing network. The company's focus on specialized drug segments ensures consistent demand from healthcare systems and institutions managing infectious diseases. Strides Pharma Science Ltd. targets healthcare institutions, distributors, and pharmaceutical companies in regions such as North America, Europe, India, and Africa, where infectious disease management requires specialized treatments. Its manufacturing presence in multiple countries supports direct market access and cost efficiency, enabling the delivery of affordable pharmaceutical solutions. The company's product portfolio emphasizes high-demand therapeutic areas, aligning with global health priorities for infectious disease treatment. Strides Pharma Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Strides Pharma Science stock

CapEx to Operating Cash Flow Ratio of Strides Pharma Science is 35.43 % in 2025.

CapEx to Operating Cash Flow Ratio of Strides Pharma Science changed from 16.86 % to 35.43 %, representing a 110.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Strides Pharma Science since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Strides Pharma Science with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Strides Pharma Science

All Key Metrics — Strides Pharma Science